Member Login
Market Reports
 |
|
In 2008, approximately 3.6 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an estimated $1.3 billion in corresponding product sales. The number of diagnostic and therapeutic PVD interventions is expected to increase at a compound annual rate of 3.7% during the forecast period covered by this report, reaching an estimated 4.3 million in the year 2013. Sales of products to perform these procedures-angiography, atherectomy, embolization, intravascular ultrasound, percutaneous transluminal angioplasty, thrombectomy, thrombolysis, vascular puncture closure, and vena cava filter systems-are projected to increase at a higher compound annual rate of 8.0% over the next half-decade, reaching nearly $2.0 billion in the year 2013.
This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional devices for the diagnosis and treatment of PVD in the U.S.
Covered topics in this report include angiography devices; catheter-directed thrombolysis products; chronic total occlusion crossing systems; cryotherapy systems; drug-eluting balloon systems; endovascular embolization products; growth factor- and stem cell-/progenitor cell-based therapeutic angiogenesis; intravascular ultrasound systems; mechanical atherectomy systems; mechanical and pharmaco-mechanical thrombectomy products; peripheral transluminal angioplasty devices; and vena cava filters. *** This is a partial list of companies, for a full listing request it ***
* Single License allows for report sharing within one company location.
Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. These conditions include aneurysm, chronic venous insufficiency, deep-vein thrombosis, peripheral artery disease, and pulmonary embolism.
EXECUTIVE SUMMARY
i. Interventional Peripheral Vascular Disease Diagnostic Products Market
a. Angiography
b. Intravascular Ultrasound
ii. Interventional Peripheral Vascular Disease Treatment Products Market
a. Percutaneous Transluminal Angioplasty
b. Catheter-Directed Thrombolysis
c. Chronic Total Occlusion Crossing
d. Mechanical Atherectomy
e. Endovascular Embolization
f. Thrombectomy
g. Vena Cava Filter Placement
h. Endovascular Cryotherapy
i. Drug-Eluting Balloon Angioplasty
iii. Methodology
Exhibit ES-1: Interventional Peripheral Vascular Disease Management, Combined Procedure Volumes Forecast, 2008-2013
Exhibit ES-2: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, 2008-2013
Exhibit ES-3: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, by Segment 2008-2013
Exhibit ES-4: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2008-2013
Exhibit ES-5: Intravascular Ultrasound Catheters, Market Forecast, 2008-2013
Exhibit ES-6: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2008-2013
Exhibit ES-7: Catheter-Directed Thrombolysis Systems, Market Forecast, 2008-2013
Exhibit ES-8: Powered Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013
Exhibit ES-9: Mechanical Atherectomy Systems, Market Forecast, 2008-2013
Exhibit ES-10: Endovascular Embolization Products, Market Forecast, 2008-2013
Exhibit ES-11: Thrombectomy Systems,Market Forecast, 2008-2013
Exhibit ES-12: Vena Cava Filter Systems, Market Forecast, 2008-2013
Exhibit ES-13: Endovascular Cryotherapy Systems, Market Forecast, 2008-2013
Exhibit ES-14: Drug Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013
1. PERIPHERAL VASCULAR DISEASE OVERVIEW
1.1 Anatomy and Physiology of the Circulatory System
1.2 Types of Peripheral Vascular Disease
1.2.1 Peripheral Artery Disease
1.2.1.1 Etiology
1.2.1.2 Epidemiology
1.2.2 Aneurysm
1.2.2.1 Etiology
1.2.2.2 Epidemiology
1.2.3 Deep Vein Thrombosis and Pulmonary Embolism
1.2.3.1 Etiology
1.2.3.2 Epidemiology
1.2.4 Chronic Venous Insufficiency
1.2.4.1 Etiology
1.2.4.2 Epidemiology
Exhibit 1-1: 2009, Peripheral Artery Disease, Facts and Figures
Exhibit 1-2: 2009, Aortic Aneurysm, Facts and Figures
Exhibit 1-3: 2009, Deep Vein Thrombosis, Facts and Figures
Exhibit 1-4: Classification of Chronic Venous Insufficiency
Exhibit 1-5: 2009, Chronic Venous Insufficiency, Facts and Figures
2. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE DIAGNOSTIC PRODUCTS MARKET
2.1 Noninvasive Peripheral Vascular Disease Diagnostics
2.1.1 Ankle/Brachial Index
2.1.2 Exercise Tolerance Testing
2.1.3 Imaging Methods
2.1.3.1 Computed Tomography
2.1.3.2 Magnetic Resonance Imaging
2.1.3.3 Thermography
2.1.3.4 Ultrasound Imaging
2.1.4 Photoplethysmography and Air Plethysmography
2.2 Interventional Peripheral Vascular Disease Diagnostics, Market Analysis
2.2.1 Angiography
2.2.1.1 Types
2.2.1.1.1 Peripheral Arterial Angiography
2.2.1.1.2 Peripheral Venous Angiography
2.2.1.2 Procedures/Technologies
2.2.1.3 Products
2.2.1.4 Market Forecast
2.2.1.5 Competitors
2.2.2 Intravascular Ultrasound
2.2.2.1 Procedures/Technologies
2.2.2.2 Products
2.2.2.3 Market Forecast
2.2.2.4 Competitors
Exhibit 2-1: Interventional Peripheral Vascular Disease Diagnosis, Combined Procedure Volumes Forecast, 2008-2013
Exhibit 2-2: Interventional Peripheral Vascular Disease Diagnostic Products, Combined Market Forecast, 2008-2013
Exhibit 2-3: Peripheral Angiography, Procedure Volumes Forecast, 2008-2013
Exhibit 2-4: 2009, Selected Angiography Catheters
Exhibit 2-5: 2009, Selected Diagnostic Guidewires
Exhibit 2-6: 2009, Selected Introducers/Sheaths
Exhibit 2-7: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2008-2013
Exhibit 2-8: 2008, Market for Angiography Devices for Peripheral Vascular Disease Diagnostics, Share by Supplier
Exhibit 2-9: Intravascular Ultrasound, Procedure Volumes Forecast, 2008-2013
Exhibit 2-10: 2009, Selected Intravascular Ultrasound Catheters
Exhibit 2-11: Intravascular Ultrasound Catheters, Market Forecast, 2008-2013
Exhibit 2-12: 2008, Intravascular Ultrasound Catheters Market, Share by Supplier
3. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE TREATMENT PRODUCTS MARKET
3.1 Noninvasive Peripheral Vascular Disease Treatments
3.1.1 Lifestyle Changes
3.1.1.1 Exercise Therapy
3.1.1.2 Diet Modification
3.1.1.3 Smoking Cessation
3.1.1.4 Compression Therapy
3.1.2 Drug Therapy
3.1.2.1 Anticoagulants and Antiplatelet Drugs
3.1.2.2 Dyslipidemia Management Drugs
3.2 Surgical/Endoscopic Peripheral Vascular Disease Treatments
3.2.1 Femoropopliteal Bypass Graft Surgery
3.2.2 Thromboendarterectomy
3.2.3 Chronic Venous Insufficiency and Venous Ulceration Treatments
3.2.3.1 Deep Vein Reconstruction
3.2.3.2 Open Subfascial Perforator Surgery
3.2.3.3 Skin Grafting
3.2.3.4 Subfascial Endoscopic Perforator Surgery
3.2.3.5 Superficial Vein Stripping
3.3 Interventional Peripheral Vascular Disease Treatments, Market Analysis
3.3.1 Percutaneous Transluminal Angioplasty
3.3.1.1 Procedures/Technologies
3.3.1.2 Products
3.3.1.2.1 Balloon Catheters
3.3.1.2.2 Guiding Catheters
3.3.1.2.3 Guidewires
3.3.1.2.4 Introducers/Sheaths
3.3.1.2.5 Accessories
3.3.1.3 Market Forecast
3.3.1.4 Competitors
3.3.2 Catheter-Directed Thrombolysis
3.3.2.1 Procedures/Technologies
3.3.2.2 Products
3.3.2.3 Market Forecast
3.3.2.4 Competitors
3.3.3 Chronic Total Occlusion Crossing
3.3.3.1 Procedures/Technologies
3.3.3.2 Products
3.3.3.3 Market Forecast
3.3.3.4 Competitors
3.3.4 Mechanical Atherectomy
3.3.4.1 Procedures/Technologies
3.3.4.2 Products
3.3.4.3 Market Forecast
3.3.4.4 Competitors
3.3.5 Endovascular Embolization
3.3.5.1 Procedures/Technologies
3.3.5.2 Products
3.3.5.3 Market Forecast
3.3.5.4 Competitors
3.3.6 Thrombectomy
3.3.6.1 Procedures/Technologies
3.3.6.2 Products
3.3.6.3 Market Forecast
3.3.6.4 Competitors
3.3.7 Vena Cava Filter Placement
3.3.7.1 Procedures/Technologies
3.3.7.2 Products
3.3.7.3 Market Forecast
3.3.7.4 Competitors
3.3.8 Other/Emerging
3.3.8.1 Endovascular Cryotherapy
3.3.8.1.1 Procedures/Technologies
3.3.8.1.2 Products
3.3.8.1.3 Market Forecast
3.3.8.2 Drug-Eluting Balloon Angioplasty
3.3.8.2.1 Procedures/Technologies
3.3.8.2.2 Products
3.3.8.2.3 Market Forecast
Exhibit 3-1: Interventional Peripheral Vascular Disease Treatment, Combined Procedure Volumes Forecast, 2008-2013
Exhibit 3-2: Interventional Peripheral Vascular Disease Treatment Products, Combined Market Forecast, 2008-2013
Exhibit 3-3: Percutaneous Transluminal Angioplasty, Procedure Volumes Forecast, 2008-2013
Exhibit 3-4: 2009, Selected Percutaneous Transluminal Angioplasty Balloon Catheters
Exhibit 3-5: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2008-2013
Exhibit 3-6: 2008, Percutaneous Transluminal Angioplasty Devices Market, Share by Supplier
Exhibit 3-7: Catheter-Directed Thrombolysis, Procedure Volumes Forecast, 2008-2013
Exhibit 3-8: 2009, Selected Catheter-Directed Thrombolysis Systems
Exhibit 3-9: Catheter-Directed Thrombolysis Systems, Market Forecast, 2008-2013
Exhibit 3-10: 2008, Catheter-Directed Thrombolysis Systems Market, Share by Supplier
Exhibit 3-11: Powered Chronic Total Occlusion Crossing, Procedure Volumes Forecast, 2008-2013
Exhibit 3-12: 2009, Selected Powered Chronic Total Occlusion Crossing Systems
Exhibit 3-13: Powered Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013
Exhibit 3-14: 2008, Powered Chronic Total Occlusion Crossing Systems Market, Share by Supplier
Exhibit 3-15: Mechanical Atherectomy, Procedure Volumes Forecast, 2008-2013
Exhibit 3-16: 2009, Selected Mechanical Atherectomy Systems
Exhibit 3-17: Mechanical Atherectomy Systems, Market Forecast, 2008-2013
Exhibit 3-18: 2008, Mechanical Atherectomy Systems Market, Share by Supplier
Exhibit 3-19: Endovascular Embolization, Procedure Volumes Forecast, 2008-2013
Exhibit 3-20: 2009, Selected Endovascular Embolization Products
Exhibit 3-21: Endovascular Embolization Products, Market Forecast, 2008-2013
Exhibit 3-22: 2008, Endovascular Embolization Products Market, Share by Supplier
Exhibit 3-23: Thrombectomy, Procedure Volumes Forecast, 2008-2013
Exhibit 3-24: 2009, Selected Thrombectomy Systems
Exhibit 3-25: Thrombectomy Systems, Market Forecast, 2008-2013
Exhibit 3-26: 2008, Thrombectomy Systems Market, Share by Supplier
Exhibit 3-27: Vena Cava Filter Placement, Procedure Volumes Forecast, 2008-2013
Exhibit 3-28: 2009, Selected Vena Cava Filter Systems
Exhibit 3-29: Vena Cava Filter Systems, Market Forecast, 2008-2013
Exhibit 3-30: 2008, Vena Cava Filter Systems Market, Share by Supplier
Exhibit 3-31: Endovascular Cryotherapy, Procedure Volumes Forecast, 2008-2013
Exhibit 3-32: Endovascular Cryotherapy Systems,Market Forecast, 2008-2013
Exhibit 3-33: Drug-Eluting Balloon Angioplasty, Procedure Volumes Forecast, 2008-2013
Exhibit 3-34: Drug-Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013
4. COMPANY PROFILES
4.1 Abbott Laboratories
4.2 AngioDynamics, Inc.
4.3 Arrow International/Teleflex, Inc.
4.4 Bacchus Vascular/Covidien LTD
4.5 C.R. Bard, Inc.
4.6 BioSphere Medical, Inc.
4.7 Boston Scientific Corporation
4.8 B. Braun Melsungen AG
4.9 Cardiovascular Systems, Inc.
4.10 Cook Group
4.11 Cordis Corporation/Johnson & Johnson
4.12 ev3, Inc.
4.13 MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group
4.14 Medtronic, Inc.
4.15 Spectranetics Corporation
4.16 Terumo Interventional Systems/Terumo Corporation
4.17 Volcano Corporation
APPENDIX: COMPANY LISTING
Abbott Laboratories
AngioDynamics, Inc.
Arrow International/Teleflex, Inc.
Bacchus Vascular/Covidien LTD
C.R. Bard, Inc.
BioSphere Medical, Inc.
Boston Scientific Corporation
B. Braun Melsungen AG
Cardiovascular Systems, Inc.
Cook Group
Cordis Corporation/Johnson & Johnson
ev3, Inc.
MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group
Medtronic, Inc.
Spectranetics Corporation
Terumo Interventional Systems/Terumo Corporation
Volcano Corporation
+ MORE
** Corporate License allows for report sharing within all company locations.
This report is listed in the following markets:
Diagnostics, Imaging and Vascular